Cite
APA Citation
Peters, S., Shaw, A. T., Besse, B., Felip, E., Solomon, B. J., Soo, R. A., Bearz, A., Gadgee, S. M., Lin, C., Kao, S., Seto, T., Masters, E. T., Abbattista, A., Clancy, J. S., Thurm, H., Reisman, A., & Camidge, D. R. (n.d.). 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095323129.0x000032